The University of Massachusetts Medical School (UMMS), the Commonwealth’s only public medical school, founded in 1962 and situated in Worcester, serves as the University’s Nobel-Prize winning health sciences campus. Perennially ranked in the top 10 percent for primary care training, UMMS has remained true to its founding mission while also becoming globally recognized in biomedical research. Today, UMMS shares a tripartite mission focused on education, research and health care delivery with its clinical partner, UMass Memorial Health Care.
UMMS is home to just under 1,100 graduate students spread among the School of Medicine, Graduate School of Biomedical Sciences and Graduate School of Nursing, almost 600 residents and fellows, and renowned faculty, including a Nobel Laureate, a Lasker Award recipient, seven Howard Hughes Investigators and five National Academy Members. UMMS’s burgeoning research enterprise, recognized for its world-class RNA-based gene-silencing expertise, attracts more than $250 million in annual research awards. UMMS’s research prominence has anchored the University’s impressive growth in research and development over the past decade and consistently positions the UMass system as a national leader in generating licensing revenue.
Unique among all medical schools, UMMS is also home to Commonwealth Medicine, a health care consulting division that partners with Massachusetts and other states in delivering health services to vulnerable populations, and MassBiologics, the only university-based and publicly owned FDA-licensed manufacturer of vaccines and other biologic products in the United States.
Given its specialized mission, internationally renowned faculty, and state-of-the-art infrastructure, UMMS is committed to leveraging its strengths and expertise to contribute to the University’s strategic growth.